Contact Lens Trial Fitting Experience
Assessment of a Novel Multifocal Contact Lens Trial Fitting Experience
1 other identifier
interventional
25
1 country
2
Brief Summary
This study will assess a trial fitting experience with contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 4, 2026
CompletedFirst Posted
Study publicly available on registry
May 22, 2026
CompletedStudy Start
First participant enrolled
May 31, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
September 1, 2026
May 22, 2026
May 1, 2026
3 months
May 4, 2026
May 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Participant Lens Fitting Experience
Participant's readiness to finalize a multifocal contact lens prescription after using an at home trial kit based on a scale of 1- 5 (1 - Good and 5 - Bad).
At the End of 15 minutes of daily wear
Study Arms (1)
Lens A ( stenfilcon A)
EXPERIMENTALAll participants will wear lens A
Interventions
Eligibility Criteria
You may qualify if:
- They are at least 40 years of age.
- They understand their rights as a research participant and are willing and able to sign a Statement of Informed Consent.
- They habitually wear MyDay sphere or MyDay Energys contact lenses (including sphere lenses for monovision, or sphere lenses for distance vision correction and spectacles for near vision correction).
- They have a minimum reading add of +0.75DS (based on their manifest refraction) and no more than +2.50DS.
- They have spherical equivalent refractive error between +4.50 to -11.00DS (some restrictions apply based on near add availability)
- They have refractive astigmatism of no greater than 0.75DC in each eye.
- They are able to achieve distance HCHL visual acuity of +0.10 logMAR or better in each eye with manifest refraction.
- They report at least one near-vision difficult symptom consistent with presbyopia as evidenced by a response of 'slight difficult' or worse on ³ 1 item of the Near Activity Visual Questionnaire (NAVQ-P) at screening.
You may not qualify if:
- Is participating in any concurrent clinical or research trial.
- They have an ocular disorder which would normally contraindicate contact lens wear.
- They have a systemic disorder which would normally contraindicate contact lens wear.
- They are pseudophakic or aphakic.
- They have had corneal refractive surgery.
- They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
- Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable.
- Self-reports as pregnant, lactating or planning a pregnancy at the time of enrollment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Bellaire Family Eye Care
Bellaire, Texas, 77401, United States
Drs. Mcintyre Garza Avila & Jurica
Corpus Christi, Texas, 78411, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2026
First Posted
May 22, 2026
Study Start (Estimated)
May 31, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05